Moderna与默沙东个性化mRNA黑色素瘤疫苗三期成功但已充分交易

▲ AI PRISM* Personalized Economic Briefing
* Editor's note: AI PRISM (Personalized Report & Insight Summarizing Media) is an AI-based personalized news recommendation and summary service developed with support from the Korea Press Foundation. It selects and provides six customized news items by reader type.
[Key Issue Briefing]
■ Dawn of mRNA Cancer Therapy: Intismeran autogene, a personalized cancer vaccine jointly developed by Moderna and Merck, demonstrated treatment efficacy in a Phase 3 trial involving 1,137 melanoma patients. This marks the first time mRNA technology has proven effective in oncology, and demand for research and development personnel in the bio and pharmaceutical fields is expected to expand rapidly.
■ Rapid Expansion of Honam Semiconductor Cluster: Samsung Electronics and SK hynix will add two more semiconductor fabs in Gwangju by 2040, bringing the total scale of fabs in the Honam region to "six-plus." As the memory chip boom lasts longer than expected, large-scale hiring of semiconductor engineers and process technology workers is expected to follow.
■ AI Literacy Emerges as Essential Skill for Job Seekers: With the Ministry of Education pursuing a national assessment of AI literacy — the ability to use AI and make critical judgments — for elementary, middle and high school students, AI competency is entering a phase of being institutionalized as an official evaluation standard. Analysts say that in the job market as well, the ability to judge and verify results, beyond simply using AI, will become a differentiating factor.
[News of Interest to University Students and Job Seekers]
1. Personalized Cancer Vaccine Succeeds in World's First Phase 3 Trial
Key summary: Moderna and Merck statistically demonstrated a cancer recurrence-suppressing effect in a Phase 3 trial in melanoma patients, using a combination therapy of the mRNA-based personalized cancer vaccine intismeran autogene and the immuno-oncology drug Keytruda. The method selects up to 34 tumor mutations specific to each patient to custom-design the mRNA, with a vaccine production period of six weeks. The two companies are conducting nine follow-up trials across six cancer types, including lung, bladder, kidney and pancreatic cancer, targeting marketing approval in 2027. Demand for research, clinical and regulatory workers in the oncology bio field is expanding rapidly, both at home and abroad.
2. [Exclusive] Two More Semiconductor Fabs to Be Built in Honam
Key summary: Samsung Electronics and SK hynix have added two fabs to their existing plan to build four fabs in the Honam region, expanding the total scale to "six-plus." The government re-estimated peak power demand in 2040 at 165 GW, nearly 20% higher than its April forecast. Investment has grown so large that additional power demand from the semiconductor sector alone will increase by 20.6 GW from previous levels. As fab expansion gains speed, new hiring demand is expected to follow in process technology, equipment and quality roles.
3. [Exclusive] AI Literacy Assessment for Schools: Common National Standard to Be Created
Key summary: The Ministry of Education will begin full-scale development in the second half of this year of a test to assess the AI literacy of elementary, middle and high school students at the national level. The assessment scope covers understanding of how AI works, the ability to use it for a given purpose, the ability to identify errors such as hallucinations, and the capacity for ethical use. It will be applied first, as early as the end of this year, to 1,141 AI-focused schools nationwide. The more the AI competency assessment system becomes institutionalized in education, the more likely it is that AI skills beyond simple use will establish themselves as a qualification standard in the job market as well.
[News for Reference for University Students and Job Seekers]
Key summary: With power demand from advanced industries and AI data centers in 2040 surging by 28.5 GW from previous estimates, the debate over energy supply has heated up. Expert opinion is gaining ground that even if renewable energy generation facilities are expanded to 200 GW, the actual supply capacity would reach only 45 GW, making nuclear and LNG supplementation unavoidable. While semiconductor fabs will begin operating around 2030, new nuclear plants will not be completed until the mid-2030s or later, prompting calls to use LNG cogeneration during the gap period. The surging demand for energy and power infrastructure is read as a promising career signal for job seekers majoring in energy engineering and electrical engineering.
Key summary: SK hynix labor and management reached a tentative agreement to raise base pay by 6.3% and pay 60% of the profit-sharing (PS) bonus in company stock. Based on a projected annual operating profit of 250 trillion won this year, the average PS per person is estimated at about 700 million won, of which about 280 million won is cash and about 420 million won is company stock. Of the company stock, 40% can be sold immediately, while the remaining 20% is deferred for two years. The spread of stock-linked compensation systems at semiconductor companies raises incentives for long-term tenure while serving as an indicator that job seekers should track for changes in compensation structure.
6. K-Robots Tighten Grip on Expanding Exports to China
Key summary: Twelve domestic robot and AI companies showcased their technologies to some 80 Chinese firms and investment institutions at the Korea-China Robot Week, co-hosted by KOTRA and KIC China, and held 72 one-on-one consultations. Goldman Sachs raised its forecast for the global humanoid robot market in 2035 to $38 billion, more than six times its previous estimate. Domestic companies in the collaborative robot, components and control software fields are moving to concretely target the Chinese market. For job seekers aiming to work in the robotics field, experience in global exhibitions and technology networking can serve as a differentiating credential.
▶ Go to article: SK hynix Wins Praise for Record Shareholder Returns as KOSPI Soars